Bionomics Announces Plans to Conduct U.S. Initial Public Offering
- Written by PR Newswire
ADELAIDE, Australia, Aug. 2, 2021 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQB: BNOEF), (Bionomics) a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to conduct a registered initial public offering of American Depositary Shares (ADSs) in the United States and a concurrent listing of ADSs on Nasdaq. The...
Read more: Bionomics Announces Plans to Conduct U.S. Initial Public Offering